TrialBlood cancer journal2018

Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study.

Joseph Mikhael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.